Table 2.
Characteristics of studies included in the systematic review (clustered where) describing unique COPD programs
| Author (year of publication) | Location | Setting
(CC; PC; SC;TC)# |
Population
|
Program type (CCM; DMP; not explicitly stated)χ | No. (types) of components (2 to 4; (Types¶)) | Study design | Study quality score (0–100) | Length of follow-up | Sample size at baseline
|
No completed
|
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean age (yrs ± sd) | Gold stage | I1/I2* | C | I1/I2* | C | ||||||||
| Aiken et al (2006)20 | United States | TC | 68.5 (±13.5) | 3 and 4 | Not stated | 3 (SMAN, DSYS, DSUP) | RCT | 60 | 18 mo | 100 | 90 | 43 | 30 |
| Bourbeau et al (2003 and 2006)32,34/Gadoury et al (2005)33 | Canada | SC | 69.5 (±7.0) | 2 and 3 | Not stated | 3 (SMAN, DSYS, DSUP) | RCT | 80 (both)/65 | 12 mo
24 mo |
95 | 95 | 86B and 91G | 79B and 84G |
| Casas et al (2006)38 | SpainIBelgium | TC | 71.2 (±9.0) | 3 and 4 | Not stated | 4 (SMAN; DSYS, DSUP, CIS) | RCT | 80 | 12 mo | 65 | 90 | 48 | 72 |
| Coultas et al (2005)21 | United States | PC | 69.0 (±8.2) | 2 and 3 | Not stated | 3 (SMAN, DSYS, DSUP) | RCT | 55 | 6 mo | 72
72 |
73 | 51/49 | 51 |
| Egan et al (2002)26 | Australia | SC | 67.5 (SD not stated) | 1–3 | DMP | 4 (SMAN; DSYS, DSUP, CIS) | RCT | 60 | 3 mo | 33 | 33 | 25 | 28 |
| Hermiz et al (2002)27 | Australia | CC and PC | 49.3 (SD not stated) | 2 and 3 | Not stated | 2 (SMAN, DSYS) | RCT | 65 | 3 mo | 84 | 93 | 67 | 80 |
| Hernandez et al (2003)37 | Spain | SC and TC | 70.8 (±9.7) | 2 and 3 | Not stated | 2 (SMAN, DSYS) | RCT | 65 | 8 wk | 121 | 101 | 116 | 94 |
| Hesselink et al (2004)35 | The Netherlands | PC | 47.3 (±13.9) | 1–4 | Not stated | 2 (SMAN, DSYS) | RCT | 80 | 24 mo | 46 | 38 | 32 | 22 |
| Jeffs et al (2005)28 | Australia | SC | 67.5 (SD not stated) | 1–4 | Not stated | 2 (SMAN, DSYS) | CCT | 55 | 12 mo | 28 | 25 | 28 | 25 |
| Lee et al (2002)39 | China | TC | 80.4 (±6.3) | 1–3 | Not stated | 3 (SMAN, DSYS, DSUP) | RCT | 65 | 6 mo | 48 | 41 | 48 | 41 |
| Poole et al (2001)30 | New Zealand | SC | 69.7 (±7.1) | 3 | Not stated | 2 (SMAN, DSYS) | CCT | 55 | 12 mo | 16 | 16 | 15 | 13 |
| Rea et al (2004)31 | New Zealand | PC | 68 (range 44–84) | 2 and 3 | DMP | 4 (SMAN; DSYS, DSUP, CIS) | RCT | 75 | 12 mo | 83 | 52 | 71 | 46 |
| Ries et al (2003)22 | United States | TC | 67.1 (±8.2) | 3 | Not stated | 2 (SMAN, DSYS) | RCT | 70 | 24 mo | 87 | 87 | 82 | 73 |
| Smith et al (1999)29 | Australia | SC | 69.9 (±1.2) | 3 | Not stated | 2 (SMAN, DSYS) | RCT | 80 | 12 mo | 48 | 48 | 36 | 36 |
| Solomon et al (1998)23/Gourley et al (1998)24 | United States | SC | 69.3 (±7.8) | 3 and 4 | DMP | 2 (SMAN, DSYS) | RCT | 60/60 | 6 mo | 43 | 55 | 43 | 54 |
| Steuten et al (2006)36 | The Netherlands | PC and SC | 61 (±14) | 1–4 | DMP | 4 (SMAN; DSYS, DSUP, CIS) | CBA | 70 | 12 mo | 317 | NA | 222 | NA |
| Weinberger et a1 (2002)25 | United States | CC | 62.4 (±11.1) | 1–3 | Not stated | 3 (SMAN, DSYS, DSUP) | RCT | 80 | 12 mo | 185/130 | 138 | 149/105 | 111 |
#
Abbreviations: CC, community care; PC, primary care; SC, secondary care; TC, tertiary care;
χ
CCM, chronic care model; DMP, disease management program; SMAN, self-management; DSYS, delivery system design; DSUP, decision support; CIS, clinical information systems; PIP, population identification processes; MEM, process and outcome measurement, evaluation and management; RFEED, routine reporting and feedback loops.
*Notes: I2, the 2nd intervention for trials with three study arms;
B
denotes study of Bourbeau et al;
G
denotes study of Gadoury et al.